ABBV R&D Expenses
AbbVie · R&D Expenses
ABBV R&D Expenses
Latest reported$9.71Bperiod ending
ABBV TTM R&D Expenses ($2.62B → $9.71B)
TTM R&D Expenses
High-resolution chart · PNG
ABBV r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 9,714,000,000 | |
| 9,501,000,000 | |
| 9,096,000,000 | |
| 13,291,000,000 | |
| 13,102,000,000 | |
| 12,919,000,000 | |
| 12,791,000,000 | |
| 8,226,000,000 | |
| 7,819,000,000 | |
| 7,604,000,000 | |
| 7,957,000,000 | |
| 7,781,000,000 | |
| 7,712,000,000 | |
| 7,857,000,000 | |
| 7,207,000,000 | |
| 7,406,000,000 | |
| 7,815,000,000 | |
| 7,836,000,000 | |
| 8,046,000,000 | |
| 8,004,000,000 | |
| 7,692,000,000 | |
| 8,228,000,000 | |
| 7,755,000,000 | |
| 7,246,000,000 | |
| 7,780,000,000 | |
| 6,727,000,000 | |
| 6,792,000,000 | |
| 11,906,000,000 | |
| 10,944,000,000 | |
| 10,884,000,000 | |
| 10,753,000,000 | |
| 5,672,000,000 | |
| 5,577,000,000 | |
| 5,499,000,000 | |
| 5,328,000,000 | |
| 4,844,000,000 | |
| 4,802,000,000 | |
| 4,752,000,000 | |
| 4,566,000,000 | |
| 4,411,000,000 | |
| 4,643,000,000 | |
| 4,453,000,000 | |
| 4,435,000,000 | |
| 4,267,000,000 | |
| 3,969,000,000 | |
| 3,815,000,000 | |
| 3,649,000,000 | |
| 3,588,000,000 | |
| 3,402,000,000 | |
| 3,331,000,000 | |
| 3,193,000,000 | |
| 3,316,221,000 | |
| 3,195,221,000 | |
| 3,168,221,000 | |
| 3,326,221,000 | |
| 3,132,129,000 | |
| 2,984,650,000 | |
| 2,822,409,000 | |
| 2,617,506,000 |